2026 · 3rd Quarter (July 1 - Sep 30)

ORGANOGENESIS INC.

Filed by ORGANOGENESIS INC..

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 19, 2026
Income: Not reported
Expenses: $24,000.00
Registrant: ORGANOGENESIS INC.
Client: ORGANOGENESIS INC.
Filing UUID: 36d986bf-2d83-4954-b8e3-b01482c8eb27
Termination date: Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products Hospital Outpatient Prospective Payment regulations regarding reimbursement for chronic wound healing products (CY2026) H.R. 5768 and S. 2561 (Skin Substitute Access and Payment Reform Act of 2025), entire bill H.R. 6852 (Advanced Wound Care and Regenerative Medicine Access and Reform Act), entire bill

Literal federal measure citations: H.R. 5768, S. 2561, H.R. 6852

HCR · Health Issues

FDA policy on chronic wound healing products

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.